Does UPADACITINIB Cause Unevaluable event? 806 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 806 reports of Unevaluable event have been filed in association with UPADACITINIB (Rinvoq). This represents 1.2% of all adverse event reports for UPADACITINIB.
806
Reports of Unevaluable event with UPADACITINIB
1.2%
of all UPADACITINIB reports
20
Deaths
232
Hospitalizations
How Dangerous Is Unevaluable event From UPADACITINIB?
Of the 806 reports, 20 (2.5%) resulted in death, 232 (28.8%) required hospitalization, and 6 (0.7%) were considered life-threatening.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 806 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which UPADACITINIB Alternatives Have Lower Unevaluable event Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL